Table Of Content

AUTHOR INDEX Volume 90 • 2002 Adachi-Akahane, S. See Futagawa, H. Ikenoue, T. See Matsuda, Y. Akiyama, K., Hora, M., Yamagishi, R. and Kitazawa, M. Im, D.-S. Tilt-induced hypotension of «i-blocker 131 Orphan G protein-coupled receptors 101 Amano, K. See Yonehara, N. Imada, T.; Komorita, N.; Kobayashi, F.; Naito, K.; Aoki, Y. See Kosugi, T. Yoshikawa, Tsutomu; Miyazaki, M.; Nakamura, N.; Aral, K. See Kamata, K. and Kondo, T. Asai, T. See Nakatani, Tatsuya Chymase inhibitor for atopic dermatitis 214 Inoue, N. See Maeda, T. Baba, A. See Mukai, K. Inui, A.; Yoshikawa, Takashi; Nagai, R.; Yoshida, N.; and Ito, T. Baba, R. See Takane, H. Mosapride enhances colonic motility 313 Bao, J. See Oishi, K. Inui, K. See Ohta, Y Broom, D.C., Jutkiewicz, E.M., Rice, K.C., Traynor, J.R. Irie, K. See Egashira, N. and Woods, J.H. Ishibashi, M. See Egashira, N. Delta-opioids 1 Ishige, A. See Ikeda, Y. Burioka, N. See Takata, M. Ishiguro, S. See Endo, S Ishihara, A. See Nakatani, Toshiaki Ciemiewski, C.S. See Swiatkowska, M. Ito, T. See Inui, A. Itoh, Y. See Fujisaki, Y. Drzewoski, J. See Swiatkowska, M. Iwai, Y. See Nakatani, Tatsuya Du, G.H. See Ren, D.C. Iwasaki, K. See Egashira, N. Iwasaki, Y., Yamato, H., Murayama, H., Takahashi, T., Ezawa, I., Egashira, N., Iwasaki, K., Ishibashi, M., Hatip-Al-Khatib, I., Kurokawa, K. and Fukagawa, M. Wolozin, B., Mishima, K., Irie, K. and Fujiwara, M. Menatetrenone prevents osteoblast dysfunction 88 Hypoxia and P-amyloid-induced apoptosis 321 Endo, S., Tomita, H., Ishiguro, S. and Tamai, M. Jang, I.Y. See Jun, J.Y Effect of betaxolol on mAAT in retinas 121 Jang, M.-H., Kim, H., Shin, M.-C., Lim, B.-V., Lee, T.-H., Enjoji, A. See Makimoto, N. Jung, S.-B., Kim, C.-J. and Kim, E.-H. Ezawa, 1. See Iwasaki, Y. Folium Mori decreases NOS expression in deabetic rats 189 Fujisaki, Y., Itoh, Y. and Oishi, R. Jun, J.Y, Yeum, C.H., Park. Y.W., Jang, I.Y., Kong, I.D., Sim, J.H., Brain permeability of Hi blockers 353 So, I., Kim, K.W. and You, H.J. Fujita, A. See Mukai, K. Arachidonic acid inhibits ATP-sensitive K' currents 81 Fujiwara, M. See Egashira, N. Jung, S.-B. See Jang, M.-H. Fukagawa, M. See Iwasaki, Y. Jutkiewicz, E.M. See Broom. D.C. Fukazawa, Y. See Maeda, T. Fukuoka, Y. See Takata, M. Kaki, H. See Suzuki, Takeo Furuichi, A. See Makimoto, N. Kamashita, K. See Sukenaga. Y. Furukawa, K. See Sasamura, S. Kamata, K., Hayashi, I., Mizoguchi, Y, Arai, K., Saeki, T., Futagawa, H., Takahashi, H., Nagao, T. and Adachi-Akahane, S. Ohno, T., Saigenji, K. and Majima, M. Block of L-type Ca’* channel by BPMC 12 Kinin and experimental colitis 59 Kamisaki, Y. See Yonehara. N. Gozu, Y. See Haze, S. Kamiya, K. See Miyamoto, S. Kaneko, A. See Ikeda, Y. Harada, N. See Kodama, N. Kanematsu, T. See Makimoto, N. Hashimoto, H. See Mukai, K. Kaneta, S. See Kosugi, T. Hashimoto, K. See Miyamoto, S. — See Yamamoto, A. Hata, F. See Mukai, K. Kano, S. See Yamamoto, A. Hatip-Al-Khatib, I. See Egashira, N. Kawakami, S. See Makimoto, N. Hayashi, I. See Kamata, K. Kim, C.-J. See Jang, M.-H. Haze, S., Sakai, K. and Gozu, Y. Kim, E.-H. See Jang, M.-H. Effects of fragrance on sympathetic activity 247 Kim, H. See Jang, M.-H. Higuchi, S. See Takane, H. Kim, K.W. See Jun, J.Y. Hora, M. See Akiyama, K. Kim, T. See Nakatani, Tatsuya Kimura, J. See Watanabe, Y. Ichihara, K. See Kosugi, T. Kishioka, S. See Maeda, T. — See Yamamoto, A. Kita, T. See Nakatani, Toshiaki Ichinosawa, K. See Yamamoto, A. Kitazawa, M. See Akiyama, K. lijima, T. See Yazawa, K. Kobayashi, F. See Imada, T. Ikeda, Y, Kaneko, A., Yamamoto, M., Ishige, A. and Sasaki, H. Kobayashi, T. See Ohta. Y. Sho-seiryii-to as anti-Th2 drug 328 Kobayashi, Y. and Okunishi, H. Author Index VI Mast cells in rheumatoid arthritis 7 Nagao, T. See Futagawa, H. Kodama, N., Harada, N. and Nanba, H. Nagasawa, Y. See Miyamoto, S. D-Fraction and Th-1 dominant response 357 Naito, K. See Imada, T. Komatsu, K. See Tohda, C. Nakajima, M. and Naya, N. Komiya, T. See Nakatani, Tatsuya Chymase contributes to tissue remodeling 206 Komorita, N. See Imada, T. Nakamura, N. See Imada, T. Kondo, T. See Imada, T. Nakashima, T. See Nakatani, Toshiaki Kong, I.D. See Jun, J.Y. Nakatani, Tatsuya; Tamada, S.; Asai, T.; Iwai, Y; Kim, T.; Kontani, H. and Shiraoya, C. Tsujino, T.; Kumata, N.; Uchida, J.; Tashiro, K.; Kuwabara, N. Prostatic and urethral responses to HGN 281 Komiya, T.; Sumi, T.; Okamura, M.; and Miura, K. Kosugi, T., Satoh, K., Kaneta, S., Aoki, Y., Takagaki, H. RoleofNF-vB in obstructive nephropathy 361 and Ichihara, K. Nakatani, Toshiaki; Nakashima, T; Kita, T; and Ishihara, A. Radical scavengers on stunned myocardium 181 Response of cigarette smoke on SOL fiber 157 Kouno, S. See Matsuda, Y. Nakazawa, S. See Ohta, Y. Koyanagi, S. See Takane, H. Nanba, H. See Kodama, N. Kubota, Y. See Umegaki, K. Naya, N. See Nakajima, M. Kumata, N. See Nakatani, Tatsuya Naya, S. See Suzuki, Takeo Kuraishi, Y. See Maekawa, T. Nisikawa, Y, Shimazoe, T, Shibata, S. and Watanabe, S. Kurokawa, K. See Iwasaki, Y. LTP in the suprachiasmatic nucleus 201 Kuwabara, N. Nakatani, Tatsuya Nojima, H. See Maekawa, T. Nomura, Y. See Tohda, M. Lee, T.-H. See Jang, M.-H. Lim, B.-V. See Jang, M.-H. Ohdo, S. See Takane, H. Liu, C.-S. and Tsai, C.-S. — See Takata, M. Epileptics with glutathione S-transferase Ml(-) genotype Ohizumi, Y. See Sasamura, S. 291 Ohno, T. See Kamata, K. Ohta, Y, Kobayashi, T, Inui, K., Yoshino, J. and Nakazawa, S. Maeda, T., Kishioka, S., Inoue, N., Shimizu, N., Fukazawa, Y., Ebselen and anti-gastric lesion effect 295 Ozaki, M. and Yamamoto, H. Ohtsuka-lsoya, M. See Wang, Y. c-Fos and morphine withdrawal in infant 270 Oishi, K., Takatoh, Y, Bao, J. and Uchida, M.K. Maekawa, T., Yamaguchi-Miyamoto, T, Nojima, H. Contraction of cerebraovascular fiber 36 and Kuraishi, Y. Oishi, R. See Fujisaki, Y. Itch-associated responses and naltrexone 193 Okamoto, Y, Takai, S. and Miyazaki, M. Majima, M. See Kamata, K. NK3201 prevents adhesion formation 94 Makimoto, N., Sakurai-Yamashita, Y., Furuichi, A., Okamura, M. See Nakatani, Tatsuya Kawakami, S., Enjoji, A., Kanematsu, T. and Taniyama, K. Okunishi, H. See Kobayashi, Y. 5-HT4 receptor in gut motility 28 Ono, K. See Yazawa, K. Matsuda, Y., Kouno, S., Sakamoto, H. and Ikenoue, T. Oudart, N. See Sercombe, R. Meluadrine on fetal hemodynamics 114 Ozaki, M. See Maeda, T. Meluadrine on uterus and hemodynamics 107 Matsumoto, N. See Tohda, C. Padilla, E. See Ruiz, E. Matsuoka, 1. See Watanabe, Y. Park, Y.W. See Jun, J.Y. Meselhy, M.R. See Tohda, C. Pawlowska, Z. See Swiatkowska, M. Mishima, K. See Egashira, N. Miura, K. See Nakatani, Tatsuya Ren, D.C., Du, G.H. and Zhang, J.T. Miyamoto, S., Zhu, B.-M., Kamiya, K., Nagasawa, Y. Water-soluble extract and cell adhesion 276 and Hashimoto, K. Rice, K.C. See Broom, D.C. Effects of KB-R7943 in dog arrhythmias 229 Ruiz, E., Padilla, E. and Tejerina, T. Miyata, M. See Takata, M. Somatostatin and rabbit coronary arteries 51 Miyazaki, M. Application of chymase inhibitor 205 Saeki, T. See Kamata, K. — See Imada, T. Saigenji, K. See Kamata, K. — See Okamoto, Y. Saito, K. See Umegaki, K. — See Sukenaga, Y. Sakai, K. See Haze, S. — See Suzuki, Takeo Sakamoto, H. See Matsuda, Y. — See Takai, S Sakamoto, S. See Wang, Y. Mizoguchi, Y. See Kamata, K. Sako, T. See Takata, M. Motomura, S. See Sasamura, S. Sakurai-Yamashita, Y. See Makimoto, N. Mukai, K., Satoh, Y., Fujita, A., Takeuchi, T., Shintani, N., Sanada, H. See Umegaki, K. Hashimoto, H., Baba, A. and Hata, F. Sasaki, H. See Ikeda, Y. PACl-mediated relaxation in mouse colon 97 Sasamura, S., Furukawa, K., Shiratori, M., Motomura, S. Murayama, H. See Iwasaki, Y. and Ohizumi, Y. Murayama, S. See Suzuki, Takeo Apoptosis induced by Ca’ -pump antisense 164 Satoh, K. See Kosugi, T. Nagai, A. See Suzuki, Takeo — See Yamamoto, A. Nagai, R. See Inui, A. Satoh, Y. See Mukai, K. Author Index Sercombe, C. See Sercombe, R. Tejerina, T. See Ruiz, E. Sercombe, R., Sercombe, C., Oudart, N. and Seylaz, J. Terazono, H. See Takata, M. Serotonin effects on basilar arteries 67 Tohda, C., Matsumoto, N., Zou, K., Meselhy, M.R. Seylaz, J. See Sercombe, R. and Komatsu, K. Shao, P. See Wang, Y. Axon and dendrite extension by diol saponins 254 Shibata, S. See Nisikawa, Y. Tohda, M., Sukma, M., Nomura, Y. and Watanabe, H. Shimazoe, T. See Nisikawa, Y. 5-HT2CR mRNA in NG108-15 cells 138 Shimizu, E. See Takata, M. Tomita, H. See Endo, S. Shimizu, N. See Maeda, T. Tomita, K. See Takata, M. Shin, M.-C. See Jang, M.-H. Traynor, J.R. See Broom, D.C. Shinoda, H. See Wang, Y Tsai, C.-S. See Liu, C.-S. Shinozuka, K. See Umegaki, K. Tsujino, T. See Nakatani, Tatsuya Shintani, N. See Mukai, K. Shiraoya, C. See Kontani, H. Uchida, J. See Nakatani, Tatsuya Shiratori, M. See Sasamura, S. Uchida, M.K. See Oishi, K. Sim, J.H. See Jun, J.Y. — See Suzuki-Nishimura, Tamiko So, I. 5(?eJun, J.Y. Umegaki, K., Saito, K., Kubota, Y, Sanada, H., Yamada, K. Sukenaga, Y, Kamoshita, K., Takai, S. and Miyazaki, M. and Shinozuka, K. NK3201 for tissue-remodeling prevention 218 Induction of CYP by Ginkgo biloba extract 345 Sukma, M. See Tohda, M. Sumi, T. See Nakatani, Tatsuya Wang, Y, Ohtsuka-Isoya, M., Shao, P., Sakamoto, S. Suyama, H. See Takata, M. and Shinoda, H. Suzuki, Takeo; Kaki, H.; Naya, S.; Murayama, S.; Tatsui, A.; Effects of methylprednisolone on rat bone 236 Nagai, A.; Takai, S.; and Miyazaki, M. Watala, C. See Swiatkowska, M. Recombinant human chymase 210 Watanabe, H. See Tohda, M. Suzuki-Nishimura, Tamiko; and Uchida, M.K. Watanabe, S. See Nisikawa, Y. Production of PGD2 in rat mast cells 77 Watanabe, Y, Matsuoka, 1. and Kimura, J. Swiatkowska, M., Pawlowska, Z., Szemraj, J., Drzewoski, J., Chronic effect of amiodarone on INCX 21 Watala, C. and Ciemiewski, C.S. Wolozin, B. See Egashira, N. Cerivastatin reduces PAl-1 promoter activity 337 Woods, J.H. See Broom, D.C. Szemraj, J. See Swiatkowska, M. Yamada, K. See Umegaki, K. Takagaki, H. See Kosugi, T. Yamagishi, R. See Akiyama, K. Takahashi, H. See Futagawa, H. Yamaguchi, T. See Takeuchi, H. Takahashi, T. See Iwasaki, Y. Yamaguchi-Miyamoto, T. See Maekawa, T. Takai, S. See Okamoto, Y. Yamamoto, A., Satoh, K., Ichinosawa, K., Kaneta, S., Kano, S. — See Sukenaga, Y. and Ichihara, K. — See Suzuki, Takeo Minoxidil on ischemic myocardium 173 Takai, S. and Miyazaki, M. Yamamoto, H. See Maeda, T. Role of chymase on vascular diseases 223 Yamamoto, M. See Ikeda, Y. Takane, H. See Takata, M. Yamato, H. See Iwasaki, Y. Takane, H., Ohdo, S., Baba, R., Koyanagi, S., Yukawa, E. Yatsugi, S. See Takeuchi, H. and Higuchi, S. Yazawa, K., Ono, K. and lijima, T. 24-Hour rhythm of interferon receptor expression 304 Mibefradil blockage of Ca*"^ entry 125 Takata, M., Burioka, N., Ohdo, S., Takane, H., Terazono, H., Yeum, C.H. See Jun, J.Y. Miyata, M., Sako, T., Suyama, H., Fukuoka, Y, Tomita, K. Yonehara, N., Amano, K. and Kamisaki, Y. and Shimizu, E. Dental injury and tactile hypersensitivity 145 Daily Per2 and Clock mRNA expression 263 Yoshida, N. See Inui, A. Takatoh, Y. See Oishi, K. Yoshikawa, Takashi See Inui, A. Takeuchi, H., Yatsugi, S. and Yamaguchi, T. Yoshikawa, Tsutomu See Imada, T. Anti-OCD effect of YM992 197 Yoshino, J. See Ohta, Y. Takeuchi, T. See Mukai, K. You, H.J. See Jun, J.Y. Tamada, S. See Nakatani, Tatsuya Yukawa, E. See Takane, H. Tamai, M. See Endo, S. Taniyama, K. See Makimoto, N. Zhang, J.T. See Ren, D.C. Tashiro, K. See Nakatani, Tatsuya Zhu, B.-M. See Miyamoto, S. Tatsui, A. See Suzuki, Takeo Zou, K. See Tohda, C. SUBJECT INDEX Volume 90 • 2002 A'-Acetyl glucosamine 77 Clock gene 263 Hypotension, orthostatic 131 Acetylcholine 51 CNQX (6-cyano-7-nitroquinoxaline-2,3- Hypotension, tilt-induced 131 Adhesion 94 dione) 321 Hypoxia 121,321 Adhesion molecule 276 Colitis, experimental 59 /7:-Adrenoceptor 107 Collagen arthritis 7 Immobilization 88 a 1-Adrenoceptor antagonist 131 Collagen gel fiber 36 In vivo microdialysis 28 Amiodarone, chronic effect 21 Colonic motility 313 Indomethacin 67 y9-Amyloid 321 Colonic smooth muscle 81 Infant rat 270 Angiotensin 11 223, 361 Compound 48/80 295 Inhibitor 214,218,223 Antigen-presenting cell 328 Conscious guinea pig 313 Inositolphosphate formation 138 Antihistaminic agent 353 Contractility 36 Interferon 304 Antisense oligodeoxynucleotide 164 Coronary artery 51 Interferon receptor 304 Aortic endothelial cell 125 Cromolyn 7 Intracerebral dopamine microdialysis Apoptosis 164, 321 Cross-sectional area 157 353 Arachidonic acid 81 Cytochrome P450 345 Ischemia 173 Arrhythmia 229 Ischemia/reperfusion 229 Artery, cerebral 67 Datura stramonium agglutinin 77 Isometric force 36 Artery, coronary 51 Dendrite 254 Itch-associated behavior 193 Arthritis, collagen 7 Dental injury model 145 Arthritis, rheumatoid 7 Depression 1 K current, ATP-sensitive 81 Aspartate aminotransferase 121 Dextran sulfate sodium 59 KATP channel 173,181 Assay 210 Diabetes, streptozotocin-induced 189 KB-R7943 (2-[2-[4-(4-nitrobenzyloxy) Atopic dermatitis 214 Digitalis 229 phenyl]ethyl]isothiourea ATP 173 Dog 229 methanesulfonate) 229 ATP-sensitive K current 81 Dopamine microdialysis, intracerebral Kininogen-deficient rat 59 Axon 254 353 KMD-3213 ((-)-1 -(3-hydroxypropyl)-5- ((2/?)-2-{[2-({2-[(2,2,2-trifluoroethyl) Bradykinin B:-receptor antagonist 59 Ebselen 295 oxy]phenyl}oxy)ethyI]amino} BALB/c mice 357 Eicosanoid 67 propyl )-2,3-dihydro-1 //-indole-7- BCEAB (4-[ 1 - {[bis-(4-methyl-phenyl)- ELISA (enzyme-linked immunosorbent carboxamide) 131 methylj-carbamoyl} -3-(2-ethoxy- assay) 210 banzyl)-4-oxo-azetidine-2-yloxy]- Endothelial cell 125, 276, 337 L-type Ca' channel 12 benzoic acid) 206 Enkephalin 1 Ligand 101 Behavior, itch-associated 193 Epilepsy 291 Lipid peroxidation 291 Behavior test, marble-burying 197 Essential oil 247 Liver, mouse 263 Betaxolol 121 Experimental colitis 59 Liver, rat 345 Bone formation 236 Long-term potentiation 201 Bone mineral density 88 Fetus 114 Lovastatin 337 Bone resorption 236 Fiber type distribution 157 BPMC (2-5ec-butylphenyl Fibrosis 206 Marble-burying behavior test 197 A-methylcarbamate) 12 Folium Mori 189 Mast cell 7, 77, 94 Bradykinin 59 Forced swim assay 1 Matrix metalloproteinases 7 Brain permeability 353 Fragrance inhalation 247 Meluadrine tartrate 114 Fura-2 125 Menatetrenone 88 c-Fos mRNA 270 Methylprednisolone 236 Ca^^ channel, L-type 12 G protein 101 Mibefradil 125 Ca^* channel inactivation 12 Gastric mucosal lesions, rat 295 Microdialysis, in vivo 28 Ca^^ concentration 125 Ginkgo hiloba 345 Microdialysis, intracerebral dopamine Calcineurin 164 Ginseng 254 353 Cardiac myocyte, guinea pig 21 Glutamate 201 Middle cerebral artery 36 Catecholamine 247 Glutathione peroxidase 295 Minoxidil 173 CD4 T cell 328 Glutathione S-transferase genotype 291 MK-801 ((5/?, 10S)-(+)-5-methyl-10,11 - CD86 328 Goat 107 dihydro-5//-dibenzo[a,<7)cycIohepten- Cell adhesion 276 5,10-imine hydrogen maleate) Cerebral artery 67 Heart rate 107,114 270,321 Cerivastatin 337 HMG-CoA reductase inhibitor 337 Modification of RNA 138 Chronopharmacokinetics 304 5-HT2C receptor 138 Morphine withdrawal 270 Chronopharmacology 304 5-HT4 receptor agonist 313 Mosapride 28 Chymase 94, 206, 210, 214, 218, 223 5-Hydroxytryptamine 51 Mosapride citrate 313 Cr channel 125 Hypogastric nerve 281 Myocardial infarction 218 Subject Index IX Myocardial stunning 181 Physiological function 210 SK-N-SH cell 254 Pituitary adenylate cyclase-activating Smooth muscle, colonic 81 NaVCa^^ exchange current 21 polypeptide 97 Smooth muscle cell, cultured 36 Naloxone 270 Plasma membrane calcium pump 164 Smooth muscle cell, vascular 164 Naltrexone 193 Polysaccharide 357 Somatostatin 51 NC mice 193 Power spectral analysis 247 Spontaneously hypertensive rat 157 N europrotection 121 Pregnancy 107 Streptozotocin-induced diabetes 189 Neutrophil 276 Pregnant goat 114 Succinate dehydrogenase activity 157 Neutrophil infiltration 295 Prostaglandin D: 77 Suprachiasmatic nucleus 201,263 NG108-15 138 Prostatic contraction, rat 281 Sympathetic nerve function 247 Nitric oxide 51,145 Protopanaxadiol saponin 254 Nitric oxide synthase 189 Tactile stimulation, hypersensitivity 145 Nitro-arginine 67 Radical scavenger 181 Tamsulosin 281 NMDA receptor 145 Receptor autoradiography 28, 313 Th differentiation 328 Non-cholinergic effect 12 Reperfusion 173 Th-1 dominance 357 Non-peptide chymase inhibitor 206 Retina 121 Thromboxane synthase 67 Nonadrenergic, noncholinergic Reverse pharmacology 101 Tilt-induced hypotension 131 relaxation 97 Rheumatoid arthritis 7 Tissue remodeling 206, 218 Nuclear factor-/rB 361 24-hour Rhythm 304 Trigeminal nucleus caudalis 145 Ritodrine hydrochloride 114 Obsessive-compulsive disorder 197 RNA editing 138 Ureteral obstruction, unilateral 361 Oligodeoxynucleotide, antisense 164 Urethral sphincter contraction 281 (!)-Opioid agonist 1 Salvia miltiorrhiza, water-soluble extract Uterus 107 Orphan G protein-coupled receptor 101 276 Orthostatic hypotension 131 Saponin, protopanaxadiol-type 254 Vascular proliferation 223 Osteoblast 236 SB20407() ((1 -«-butyl-4-piperidinyl) Vascular smooth muscle cell 164 Osteoblast function 88 methyl-8-amino-7-iodo-1,4-benzo- Osteoclast 236 dioxane-5-carboxylate) 28 Wheat germ agglutinin 77 Serotonin 51 Wistar-Kyoto rat 157 PAC1 receptor 97 Serotonin 4 receptor agonist 313 YM992 ((S)-2-[[(7-fluoroindan-4-yl) PAl-1 promoter activity 337 Serotonin 2C subtype receptor 138 oxy]methyl]morpholine) Pentoxyresorufin O-dealkylase 345 Sho-sein’u-to 328 monohydrochloride 197 Per2 263 Silkworm-baculovirus expression Peripheral blood mononuclear cell 263 system 210